pentasa enema
ferring pharmaceuticals ltd - mesalazine - enema - mesalazine 1 g / 100 ml - aminosalicylic acid and similar agents - ulcerative colitis - chron's disease
desloratadine 0.5 mg/ml oral solution
rosemont pharmaceuticals ltd - desloratidine - oral solution - 0.5 mg/ml - other antihistamines for systemic use - antihistamines – h1 antagonist - it is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with: allergic rhinitis, urticaria
ethambutol 400 mg tablets
peckforton pharmaceuticals ltd - ethambutol hydrochloride - film-coated tablet - 400 mg - antimycobacterial - it is indicated for the primary treatment and re-treatment of tuberculosis and for prophylaxis in cases of inactive tuberculosis or large-tuberculinpositive reaction
ethambutol 100 mg tablets
peckforton pharmaceuticals ltd - ethambutol hydrochloride - film-coated tablet - 100 mg - antimycobacterial - it is used for the primary treatment and re-treatment of tuberculosis and for prophylaxis in cases of inactive tuberculosis or large-tuberculinpositive reaction.
rivastigmine rosemont 2mg/ml oral solution
rosemont pharmaceuticals ltd - rivastigmine hydrogen tartrate - oral solution - 2mg for ml - psychoanaleptics, anticholinesterases - symptomatic treatment of mild to moderately severe alzheimer's dementia; symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.
amlodipine 2mg/ml oral solution
rosemont pharmaceuticals ltd - amlodipine - oral solution - 2 mg/ml - calcium channel blockers, selective calcium channel blockers with mainly vascular effects - hypertension; chronic stable angina pectoris; vasospastic (prinzmetal's) angina
amlodipine 1mg/ml oral solution
rosemont pharmaceuticals ltd - amlodipine - oral solution - 1mg/ml - calcium channel blockers, selective calcium channel blockers with mainly vascular effects - hypertension; chronic stable angina pectoris; vasospastic (prinzmetal's) angina
methotrexate
rosemont pharmaceuticals ltd - methotrexate disodium - oral solution - 2 mg/ml - methotrexate - antineoplastic and immunomodulating agents, antimetabolites, folic acid analogues - it is indicated in the following oncological indications: the maintenance treatment of acute lymphocytic leukaemia (all) in children and adults; the treatment of malignant trophoblastic tumours and for the treatment of severe active rheumatoid arthritis in adults and the treatment of severe forms of psoriasis vulgaris including chronic plaque psoriasis, erythrodermic psoriasis, psoriatic arthritis and pustular psoriasis which are not responsive to other conventional therapies such as phototherapy, puva and retinoids.
perizam 1mg/ml oral suspension
rosemont pharmaceuticals ltd - clobazam - oral suspension - 1 milligram(s)/millilitre - benzodiazepine derivatives; clobazam - anxiolytics - it is indicated in adults for the short-term symptomatic treatment (2-4 weeks) only of anxiety that is severe, disabling or subjecting the individual to unacceptable distress. in treatment of anxiety states associated with affected disorders, perizam must only be used in conjunction with adequate treatments for the underlying disorder. in patients with schizophrenic or other psychotic illnesses, use of benzodiazepines is recommended only for short term symptomatic management of hyperarousal and agitation. benzodiazepines do not possess antipsychotic properties. perizam may be used as adjunctive therapy in epilepsy in adults or children over 6, if standard treatment with one or more anticonvulsants has failed.
perizam 2mg/ml oral suspension
rosemont pharmaceuticals ltd - clobazam - oral suspension - 2 milligram(s)/millilitre - benzodiazepine derivatives; clobazam - anxiolytics - it is a 1,5-benzodiazepine indicated in adults for the short-term symptomatic treatment (2-4 weeks) only of anxiety that is severe, disabling or subjecting the individual to unacceptable distress. in treatment of anxiety states associated with affected disorders, perizam must only be used in conjunction with adequate treatments for the underlying disorder. in patients with schizophrenic or other psychotic illnesses, use of benzodiazepines is recommended only for short term symptomatic management of hyperarousal and agitation. benzodiazepines do not possess antipsychotic properties. perizam may be used as adjunctive therapy in epilepsy in adults or children over 6, if standard treatment with one or more anticonvulsants has failed.